The high potency APIs market will rake USD 49.1 billion in revenues while expanding with an 9% CAGR in the 2023-2032. The High Potency Active Pharmaceutical Ingredients (HPAPI) market is experiencing significant growth, driven by the rising demand for targeted therapies and the increasing prevalence of chronic diseases. HPAPIs, also known as Highly Potent Active Pharmaceutical Ingredients, are...